<--- Back to Details
First PageDocument Content
Carcinogens / Astrochemistry / Origin of life / Oncology / Aromatic hydrocarbon / Dibenz(a / h)anthracene / Fluoranthene / Benzo(a)pyrene / Anthracene / Chemistry / Medicine / Polycyclic aromatic hydrocarbons
Date: 1998-09-02 03:00:00
Carcinogens
Astrochemistry
Origin of life
Oncology
Aromatic hydrocarbon
Dibenz(a
h)anthracene
Fluoranthene
Benzo(a)pyrene
Anthracene
Chemistry
Medicine
Polycyclic aromatic hydrocarbons

ENVIRONMENTAL CONTAMINANTS ENCYCLOPEDIA DIBENZ(A,H)ANTHRACENE [DIBENZO(A,H)ANTHRACENE] ENTRY July 1, 1997 COMPILERS/EDITORS:

Add to Reading List

Source URL: www.nature.nps.gov

Download Document from Source Website

File Size: 68,30 KB

Share Document on Facebook

Similar Documents

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

DocID: 1xVse - View Document

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

DocID: 1xViy - View Document

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

DocID: 1xV2d - View Document

Formal Specication and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

Formal Speci cation and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

DocID: 1xUvZ - View Document

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

DocID: 1xTgE - View Document